Heron Therapeutics | HRTX - Loan Capital


Heron Therapeutics reported $140.64M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
ALKERMES USD 1.48B 7.23M Jun/2026
Alnylam Pharmaceuticals USD 2.47B 6.56M Jun/2026
ANI Pharmaceuticals USD 280.15M 5.84M Jun/2026
Arrowhead Research USD 824.07M 401.34M Jun/2026
Eisai JPY 184.6B 49.83B Jun/2026
Emergent BioSolutions USD 446.5M 1.7M Dec/2023
GlaxoSmithKline GBP 13.95B 65M Jun/2026
Heron Therapeutics USD 140.64M 975K Dec/2025
Insmed USD 543.51M 1.3M Jun/2026
Ligand Pharmaceuticals USD 446.9M 704K Mar/2026
Merck USD 51.08B 4.41B Jun/2026
Nektar Therapeutics USD 60.27M 2.89M Mar/2026
Neurocrine Biosciences USD 169.5M 500K Mar/2023
Omeros USD 403.72M 27.2M Jun/2024
Pacira USD 363.12M 4.53M Jun/2026
Regeneron Pharmaceuticals USD 1.99B 400K Jun/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
Sangamo BioSciences USD 0 0 Jun/2022
Ultragenyx Pharmaceutical USD 1.13B 19M Mar/2026
Veracyte USD 0 0 Mar/2025
Vertex Pharmaceuticals USD 106.7M 4.7M Dec/2025